Sensex Declines Amid Geopolitical Tensions and Pharma Sector Weakness
Sensex drops 400 pts; pharma shares decline
Business Standard
Image: Business Standard
The S&P BSE Sensex dropped 399.73 points (0.55%) to 72,964.56 as geopolitical tensions between the US and Iran weighed on investor sentiment. The Nifty Pharma index fell 1.19%, marking a 4.98% decline over five consecutive sessions, reflecting broader market volatility and caution ahead of the Reserve Bank of India's monetary policy meeting.
- 01S&P BSE Sensex fell 399.73 points to 72,964.56.
- 02Nifty Pharma index declined 1.19%, down 4.98% over five sessions.
- 03Investor caution linked to geopolitical tensions and upcoming RBI policy meeting.
- 04IndusInd Bank reported a 2.6% decline in deposits year-on-year.
- 05Ongoing volatility in oil and gas shares continues to impact market performance.
Advertisement
In-Article Ad
In mid-morning trading, the S&P BSE Sensex recorded a decline of 399.73 points or 0.55%, settling at 72,964.56. The Nifty 50 index also fell 111.60 points (0.49%) to 22,601.50, reflecting a cautious investor sentiment amid rising geopolitical tensions between the United States and Iran. The Nifty Pharma index dropped 1.19%, marking a 4.98% decline over the last five sessions, with significant losses reported by major pharmaceutical companies such as Piramal Pharma and Sun Pharmaceutical Industries. The broader market showed a mixed performance, with the BSE 150 MidCap Index down 0.03% and the BSE 250 SmallCap Index down 0.07%. Despite the overall decline, the market breadth remained positive with 2,426 shares rising against 1,623 shares that fell. The Reserve Bank of India's Monetary Policy Committee is expected to maintain the repo rate at 5.25% during its upcoming meeting, as inflationary pressures and geopolitical risks continue to loom. In global markets, stocks in Japan and South Korea rose, while concerns over the Middle East conflict persisted, impacting oil prices and investor confidence.
Advertisement
In-Article Ad
The decline in the Sensex and pharma stocks could affect investor confidence and market stability, potentially impacting investment decisions and economic growth.
Advertisement
In-Article Ad
Reader Poll
How do you view the current state of the stock market amid geopolitical tensions?
Connecting to poll...
More about Reserve Bank of India
Read the original article
Visit the source for the complete story.



